Noramco™
Anthony Ambrosini is currently the Vice President - Finance and Business Development at Noramco™ since July 2016. Prior to their current role, Anthony worked at Johnson & Johnson for 17 years, where Anthony held various financial positions, including Controller for the Worldwide Narcotics Franchise. Anthony has a strong background in finance, with experience in managing global finance teams, overseeing financial functions, and leading financial activities associated with divestitures and partnerships. Anthony holds an MBA in Economics from West Chester University of Pennsylvania and a BS in Accounting/Finance from Temple University.
Noramco™
Noramco, headquartered in Wilmington, Delaware, is a global leader in the production of controlled substances for the pharmaceutical industry, for medicines used to treat attention deficit hyperactivity disorder, pain, addiction, and for abuse-deterrent formulations. We realize our success through a keen focus on commercial and operational excellence as well as continuing strategic growth. Our global footprint includes Athens, GA, Wilmington, DE and Neuhausen, Switzerland. Specialists in controlled substance development and manufacturing, Noramco is a partner to the pharmaceutical industry: – Focusing on high-purity controlled substances – Leveraging intellectual property to devise the most efficient routes to APIs – Providing analytical data, chemical and physical properties, stability studies and regulatory assistance – Formulation friendly particle size grades and extended technical packages – Delivering DEA-compliant security and production capacity, from kilos to multi-ton supply – Supporting world-class supply security of controlled-substances, from schedule I to schedule III